| Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation | |
| Wen, Sailan; Liu, Yuwu; Yang, Manyi; Yang, Keda; Huang, Jianghai; Feng, Deyun* | |
| 刊名 | Oncology Reports
 |
| 2016 | |
| 卷号 | 36期号:4页码:2193-2199 |
| 关键词 | Drug resistance Hepatocellular carcinoma NIMA-related expressed kinase 2 PP1/Akt Wnt |
| ISSN号 | 1791-2431 |
| DOI | 10.3892/or.2016.5009 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000383732600050 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3341669 |
| 专题 | 中南大学 |
| 作者单位 | 1.[Wen, Sailan 2.Huang, Jianghai] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Wen, Sailan,Liu, Yuwu,Yang, Manyi,et al. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation[J]. Oncology Reports,2016,36(4):2193-2199. |
| APA | Wen, Sailan,Liu, Yuwu,Yang, Manyi,Yang, Keda,Huang, Jianghai,&Feng, Deyun*.(2016).Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.Oncology Reports,36(4),2193-2199. |
| MLA | Wen, Sailan,et al."Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation".Oncology Reports 36.4(2016):2193-2199. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论